Growth Equity Opportunities 17, LLC SEC EDGAR Filings (CIK 0001790256)

SEC EDGAR filings, ownership reports, and insider transactions for Growth Equity Opportunities 17, LLC.

Business address
1954 Greenspring Drive, Suite 600, Timonium, MD, 21093
Top holdings (ownership)
SVRA
Top holdings (Schedule 13D)
SVRA
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Growth Equity Opportunities 17, LLC has filed 14 SEC EDGAR filings since 04 Jun 2020

Latest Filings

Recent SEC filings for Growth Equity Opportunities 17, LLC including SCHEDULE 13D/A, SC 13D/A, 4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 14 Nov 2025
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC / SAVARA INC -- 13D/A(#2) 14 Aug 2024
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC / SAVARA INC -- 13D/A(#1) 26 Jul 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Jul 2023 17 Jul 2023 001-32157
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D/A(#2E) 02 May 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC -- SCH 13D/A(#1E) 03 Feb 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D/A(#1) 27 Jan 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC -- VISTAGEN--SCH 13D/A(#2E) 12 Aug 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC -- VISTAGEN--SCH 13D/A(#1) 29 Apr 2021
SC 13D Open SC 13D document View SEC filing for SC 13D GROWTH EQUITY OPPORTUNITIES 17, LLC / SAVARA INC -- 13D 25 Mar 2021
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 16 Mar 2021 15 Mar 2021 001-32157
SC 13D Open SC 13D document View SEC filing for SC 13D GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D 15 Mar 2021
SC 13D Open SC 13D document View SEC filing for SC 13D GROWTH EQUITY OPPORTUNITIES 17, LLC -- VISTAGEN--SCH 13D 04 Jan 2021
SC 13D Open SC 13D document View SEC filing for SC 13D GROWTH EQUITY OPPORTUNITIES 17, LLC -- SCH 13D 04 Jun 2020

About this filer

Growth Equity Opportunities 17, LLC files with the SEC under CIK 0001790256. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages